These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 32504737)
1. The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination. Parikh SR; Campbell H; Bettinger JA; Harrison LH; Marshall HS; Martinon-Torres F; Safadi MA; Shao Z; Zhu B; von Gottberg A; Borrow R; Ramsay ME; Ladhani SN J Infect; 2020 Oct; 81(4):483-498. PubMed ID: 32504737 [TBL] [Abstract][Full Text] [Related]
2. The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines. Pelton SI J Adolesc Health; 2016 Aug; 59(2 Suppl):S3-S11. PubMed ID: 27449148 [TBL] [Abstract][Full Text] [Related]
3. Meningococcal vaccine evolution. Bona G; Guidi C J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004-2014. Whittaker R; Dias JG; Ramliden M; Ködmön C; Economopoulou A; Beer N; Pastore Celentano L; Vaccine; 2017 Apr; 35(16):2034-2041. PubMed ID: 28314560 [TBL] [Abstract][Full Text] [Related]
5. Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies. Booy R; Gentile A; Nissen M; Whelan J; Abitbol V Hum Vaccin Immunother; 2019; 15(2):470-480. PubMed ID: 30296197 [TBL] [Abstract][Full Text] [Related]
6. Meningococcal invasive disease by serogroup W and use of ACWY conjugate vaccines as control strategy in Chile. Villena R; Valenzuela MT; Bastías M; Santolaya ME Vaccine; 2019 Oct; 37(46):6915-6921. PubMed ID: 31585728 [TBL] [Abstract][Full Text] [Related]
7. Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands. Bousema JC; Ruitenberg J Int J Health Policy Manag; 2015 Sep; 4(11):757-61. PubMed ID: 26673336 [TBL] [Abstract][Full Text] [Related]
8. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523 [TBL] [Abstract][Full Text] [Related]
9. Evolving strategies for meningococcal vaccination in Europe: Overview and key determinants for current and future considerations. Martinón-Torres F; Taha MK; Knuf M; Abbing-Karahagopian V; Pellegrini M; Bekkat-Berkani R; Abitbol V Pathog Glob Health; 2022 Mar; 116(2):85-98. PubMed ID: 34569453 [TBL] [Abstract][Full Text] [Related]
10. Novel quadrivalent meningococcal A, C, W-135 and Y glycoconjugate vaccine for the broader protection of adolescents and adults. Pace D Future Microbiol; 2010 Nov; 5(11):1629-40. PubMed ID: 21133685 [TBL] [Abstract][Full Text] [Related]
11. Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB. Bekkat-Berkani R; Fragapane E; Preiss S; Rappuoli R; Sohn WY; Soumahoro L; Vadivelu K J Infect; 2022 Nov; 85(5):481-491. PubMed ID: 36087745 [TBL] [Abstract][Full Text] [Related]
12. Prevention and control of meningococcal disease: Updates from the Global Meningococcal Initiative in Eastern Europe. Bai X; Borrow R; Bukovski S; Caugant DA; Culic D; Delic S; Dinleyici EC; Eloshvili M; Erdősi T; Galajeva J; Křížová P; Lucidarme J; Mironov K; Nurmatov Z; Pana M; Rahimov E; Savrasova L; Skoczyńska A; Smith V; Taha MK; Titov L; Vázquez J; Yeraliyeva L J Infect; 2019 Dec; 79(6):528-541. PubMed ID: 31682877 [TBL] [Abstract][Full Text] [Related]
13. Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. Poland GA Clin Infect Dis; 2010 Mar; 50 Suppl 2():S45-53. PubMed ID: 20144016 [TBL] [Abstract][Full Text] [Related]
14. Invasive Meningococcal Disease in Africa's Meningitis Belt: More Than Just Meningitis? Reese HE; Ronveaux O; Mwenda JM; Bita A; Cohen AL; Novak RT; Fox LM; Soeters HM J Infect Dis; 2019 Oct; 220(220 Suppl 4):S263-S265. PubMed ID: 31671435 [TBL] [Abstract][Full Text] [Related]
15. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature. Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt. Kuznik A; Iliyasu G; Lamorde M; Mahmud M; Musa BM; Nashabaru I; Obaro S; Mohammed I; Habib AG PLoS One; 2017; 12(11):e0188595. PubMed ID: 29190699 [TBL] [Abstract][Full Text] [Related]
17. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia. Marshall HS; Lally N; Flood L; Phillips P Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501 [TBL] [Abstract][Full Text] [Related]
18. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies? Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392 [TBL] [Abstract][Full Text] [Related]
19. Vaccines against Meningococcal Diseases. Pizza M; Bekkat-Berkani R; Rappuoli R Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33022961 [No Abstract] [Full Text] [Related]